Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters)
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
There are evidences of functional growth hormone (GH) deficiency, expressed by means of low
serum levels of insulin-like growth factor 1 (IGF-1), in a subset of fibromyalgia patients.
The efficacy of low GH doses versus placebo has been demonstrated in this population. We
assessed the efficacy and safety of GH added to standard therapy compared to standard therapy
alone in the treatment of severe, prolonged and well-treated fibromialgya patients with low
IGF-1 levels.
Phase:
Phase 2
Details
Lead Sponsor:
Centro Medico Teknon
Treatments:
Amitriptyline Amitriptyline, perphenazine drug combination Fluoxetine Hormones Tramadol